874 results on '"Guenova, Emmanuella"'
Search Results
2. MHC-I upregulation safeguards neoplastic T cells in the skin against NK cell-mediated eradication in mycosis fungoides
3. Unilateral relapsing purpura on the leg as a first manifestation of IgG lymphoplasmacytic lymphoma
4. Keratinocytes Present Staphylococcus aureus Enterotoxins and Promote Malignant and Nonmalignant T Cell Proliferation in Cutaneous T-Cell Lymphoma
5. Radiotherapy in cutaneous lymphomas: Recommendations from the EORTC cutaneous lymphoma tumour group
6. Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study
7. Staphylococcus aureus induces drug resistance in cancer T cells in Sézary syndrome
8. SARS-CoV-2–Induced Vasculitic Skin Lesions Are Associated with Massive Spike Protein Depositions in Autophagosomes
9. Evaluating Response Trends of Chlormethine/Mechlorethamine Gel in Patients With Stage I-IIA Mycosis Fungoides: Analysis of Individual Patient Data From a Randomized Controlled Phase II Study to Facilitate Optimal Treatment Experiences
10. Th17-associated cytokines IL-17 and IL-23 in inflamed skin of Darier disease patients as potential therapeutic targets
11. Papuloerythroderma of Ofuji (PEO) successfully treated with acitretin
12. EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2023
13. Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion
14. Cutaneous presentation of enteropathy-associated T-cell lymphoma masquerading as a DUSP22-rearranged CD30+ lymphoproliferation
15. Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC
16. Maintenance therapy for CTCL: importance for prevention of disease progression.
17. Increased Chlormethine-Induced DNA Double-Stranded Breaks in Malignant T Cells from Mycosis Fungoides Skin Lesions
18. The cGAS–STING pathway drives type I IFN immunopathology in COVID-19
19. BPDCN: die frühe Diagnose ist entscheidend
20. Evolution of patients with Sézary syndrome after mogamulizumab discontinuation for any cause except progression: a multicenter retrospective study (Moga-stop study)
21. Decoding the impact of primary cutaneous B‐cell lymphomas on patients' well‐being
22. Paediatric onset lymphomatoid papulosis: results of a multicentre retrospective cohort study, on behalf of the EORTC Cutaneous Lymphoma Tumours Group (CLTG)
23. Real-world study on the use of pegylated interferon alpha-2a for treatment of mycosis fungoides/Sézary syndrome using Time to Next Treatment as a measure of clinical benefit: An EORTC CLTG study
24. Programmed death ligand 2 expression plays a limited role in adenocarcinomas of the gastroesophageal junction after preoperative chemotherapy
25. Correction to: Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion
26. Artificial neural networks and pathologists recognize basal cell carcinomas based on different histological patterns
27. Oncolytic virotherapy-mediated anti-tumor response: a single-cell perspective
28. Spontaneous regression of primary cutaneous diffuse large B‐cell lymphoma, leg type: A case series and review of the literature.
29. Real-world study of pegylated interferon α-2a to treat mycosis fungoides/Sézary syndrome using time to next treatment as a measure of clinical benefit: an EORTC CLTG study.
30. Synthetic mRNAs Containing Minimalistic Untranslated Regions Are Highly Functional In Vitro and In Vivo.
31. Cryoglobulinemic vasculitis triggered by Staphylococcus aureus endocarditis with chronic hepatitis C virus co-infection: a case report and literature review.
32. Ein Fall von papulöser akantholytischer Dyskeratose mit IL‐23/TNF‐α‐dominantem Immunprofil
33. Mosaic RASopathies concept: different skin lesions, same systemic manifestations?
34. Resminostat for Maintenance Treatment in Patients with Advanced Stage Mycosis Fungoides or Sézary Syndrome: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase 2 Trial
35. Aspects physiopathologiques cliniques et thérapeutiques de la maladie de Darier
36. Dermatoses bulleuses auto-immunes chez les enfants
37. Old Sins Cast Long Shadows: News on Staphylococcus aureus in Cutaneous T Cell Lymphoma
38. Hypersensitivity reactions to non-steroidal anti-inflammatory drugs: results of an Austrian cohort study
39. Sensitivity and specificity of T-cell receptor PCR BIOMED-2 clonality analysis for the diagnosis of cutaneous T-cell lymphoma
40. Dualism of FGF and TGF-β Signaling in Heterogeneous Cancer-Associated Fibroblast Activation with ETV1 as a Critical Determinant
41. Mogamulizumab Combined with Extracorporeal Photopheresis as a Novel Therapy in Erythrodermic Cutaneous T-cell Lymphoma
42. Two different types of tandem sequences mediate the overexpression of TinCYP51B in azole-resistant Trichophyton indotineae
43. From Childhood Trauma to immunocellular health: Unveiling the Link between Adverse Experiences and Depression
44. Single‐centre experience with tralokinumab in dupilumab‐experienced and naïve patients with atopic dermatitis.
45. 987: Pattern-of-Care Analysis for Radiotherapy of Cutaneous Lymphomas Among EORTC Members
46. Ex vivo harmonic generation microscopy assessment in cutaneous T-cell lymphomas diagnosis
47. Lymphomatoid papulosis in paediatric population: results of a multicentre retrospective cohort study
48. Evaluating Response Trends of Chlormethine/Mechlorethamine Gel in Patients With Stage I-IIA Mycosis Fungoides: Analysis of Individual Patient Data From a Randomized Controlled Phase II Study to Facilitate Optimal Treatment Experiences
49. RESMAIN: results of a multicenter, randomized, double blind, placebocontrolled trial to evaluate resminostat for maintenance treatment in advanced stage mycosis fungoides or Sézary syndrome
50. T cell receptor beta constant 1 as a potential marker to better assess T cell clonality in skin samples
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.